Filing Details
- Accession Number:
- 0000899243-17-026590
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-16 16:14:31
- Reporting Period:
- 2017-11-14
- Accepted Time:
- 2017-11-16 16:14:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1537917 | Tyme Technologies Inc. | TYME | Pharmaceutical Preparations (2834) | 453864597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1712467 | Michael Demurjian | C/O Tyme Technologies, Inc. 44 Wall Street - 12Th Floor New York NY 10005 | Chief Operating Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-14 | 50,000 | $3.34 | 26,680,436 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
